Phase 1 randomized, parallel and pharmacokinetics study meloxicam and esomeprazole after single and multiple dose administration of AXS-06 in healthy volunteers.

Trial Profile

Phase 1 randomized, parallel and pharmacokinetics study meloxicam and esomeprazole after single and multiple dose administration of AXS-06 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Esomeprazole/meloxicam (Primary) ; Esomeprazole; Meloxicam
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Jul 2017 Status changed from not stated to completed.
    • 31 Jul 2017 New trial record
    • 25 Jul 2017 Primary endpoint (time to maximum plasma concentration (Tmax) of meloxicam versus Mobic) has been met, according to an Axsome Therapeutics Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top